tiprankstipranks
Trending News
More News >
Outlook Therapeutics (OTLK)
:OTLK
US Market
Advertisement

Outlook Therapeutics (OTLK) Technical Analysis

Compare
1,511 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Outlook Therapeutics’s (OTLK) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Outlook Therapeutics is a Buy.
Outlook Therapeutics’s (OTLK) 20-Day exponential moving average is 1.29, while Outlook Therapeutics’s (OTLK) share price is $1.28, making it a Sell.
Outlook Therapeutics’s (OTLK) 50-Day exponential moving average is 1.36, while Outlook Therapeutics’s (OTLK) share price is $1.28, making it a Sell.

Outlook Therapeutics (OTLK) Pivot Points

Oct 31, 2025, 03:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.18
1.22
1.25
1.29
1.32
1.36
1.39
Fibonacci
1.22
1.25
1.26
1.29
1.32
1.33
1.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Outlook Therapeutics (OTLK) Moving Averages

Oct 31, 2025, 03:38 PM
Period
Simple
Exponential
MA5
1.32Sell
1.30Sell
MA10
1.34Sell
1.31Sell
MA20
1.30Sell
1.29Sell
MA50
1.28Sell
1.36Sell
MA100
1.63Sell
1.53Sell
MA200
1.62Sell
1.78Sell
Outlook Therapeutics’s (OTLK) 10-Day exponential moving average is 1.31, while Outlook Therapeutics’s (OTLK) share price is $1.28, making it a Sell.
Outlook Therapeutics’s (OTLK) 100-Day exponential moving average is 1.53, while Outlook Therapeutics’s (OTLK) share price is $1.28, making it a Sell.
Outlook Therapeutics’s (OTLK) stock price is $1.28 and Outlook Therapeutics’s (OTLK) 50-day simple moving average is 1.28, creating a Sell signal.
Outlook Therapeutics’s (OTLK) stock price is $1.28 and Outlook Therapeutics’s (OTLK) 100-day simple moving average is 1.63, creating a Sell signal.
Outlook Therapeutics’s (OTLK) stock price is $1.28 and Outlook Therapeutics’s (OTLK) 200-day simple moving average is 1.62, creating a Sell signal.

Outlook Therapeutics (OTLK) Technical Indicators

Oct 31, 2025, 03:38 PM
Name
Value
Implied Action
RSI (14)
46.85
Neutral
STOCH (9,6)
13.75
Buy
STOCHRSI (14)
25.23
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
18.99
Buy
Williams %R
-93.75
Buy
CCI (14)
-33.73
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
41.21
Neutral
ROC
3.33
Buy
Outlook Therapeutics’s (OTLK) Relative Strength Index (RSI) is 46.85, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Trend Strength Indicator (ADX) is 18.99, creating a Buy signal.
Outlook Therapeutics’s (OTLK) Commodity Channel Index (CCI) is -33.73, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Price Rate of Change (ROC) is 3.33, creating a Buy signal.

FAQ

Is OTLK a Buy, Hold, or Sell?
Based on OTLK’s technical indicators, OTLK is a Sell.
    What is OTLK’s RSI (14)?
    OTLK’s RSI (14) is 46.85, which suggests OTLK is a Neutral.
      What is OTLK’s MACD?
      OTLK’s MACD is 0.02, which suggests OTLK is a Buy.
        What is OTLK’s 5-day moving average?
        OTLK’s 5-day moving average is 1.32, which suggests OTLK is a Sell.
          What is OTLK’s 20-day moving average?
          OTLK 20-day moving average is 1.30, which suggests OTLK is a Sell.
            What is OTLK’s 50-day moving average?
            OTLK’s 50-day moving average is 1.28, which suggests OTLK is a Sell.
              What is OTLK’s 200-day moving average?
              OTLK’s 200-day moving average is 1.62, which suggests OTLK is a Sell.
                What is OTLK’s Williams % R (14)?
                OTLK’s Williams % R (14) is -93.75, which suggests OTLK is a Buy.
                  What is OTLK’s CCI (14)?
                  OTLK’s CCI (14) is -33.73, which suggests OTLK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis